Last updated: May 29, 2026

Application No. 18/341,584

COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH AN IMPRINTING DEFECT

Non-Final OA

Filed

Jun 26, 2023

Priority

Jul 19, 2017 — provisional 62/534,532 +2 more

Examiner

ANDERSON, JAMES D

Art Unit

1629

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

The Children's Hospital of Philadelphia

OA Round

1 (Non-Final)

This examiner grants 55% of cases after interview

— +19.2% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1322 resolved cases, 2023–2026

Examiner Intelligence

ANDERSON, JAMES D View full profile →

Grants 55% of resolved cases

Career Allowance Rate

729 granted / 1322 resolved

-4.9% vs TC avg

Strong +19% interview lift

Without

With

+19.2%

Interview Lift

resolved cases with interview

Typical timeline

2y 10m

Avg Prosecution

21 currently pending

Career history

1357

Total Applications

across all art units

Statute-Specific Performance

§101

0.9%

-39.1% vs TC avg

§103

35.7%

-4.3% vs TC avg

§102

22.8%

-17.2% vs TC avg

§112

11.4%

-28.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1322 resolved cases

Prosecution Timeline

Jun 26, 2023

Application Filed

Dec 08, 2023

Response after Non-Final Action

Sep 08, 2025

Non-Final Rejection mailed

Jan 05, 2026

Response after Non-Final Action

Jan 05, 2026

Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/618,215

Patent 12636273

COMPOSITIONS FOR PATHOGENESIS-DIRECTED THERAPY AND TREATMENTS OF SKIN DISEASES AND DISORDERS

4y 5m to grant Granted May 26, 2026

18/169,999

Patent 12638439

METHOD OF USING HUMAN SPHEROIDS FOR DRUG DISCOVERY

3y 3m to grant Granted May 26, 2026

18/419,027

Patent 12616668

NUTRITIONAL SUPPLEMENT CONTAINING L-a-GLYCEROPHOSPHORYLCHOLINE

2y 3m to grant Granted May 05, 2026

18/265,865

Patent 12612354

CYCLOPENTENONES DERIVATIVES AND THEIR USE AS ANTIBIOTICS

2y 10m to grant Granted Apr 28, 2026

18/357,985

Patent 12612362

ANISOMYCIN DERIVATIVE AND USE OF ANISOMYCIN AND DERIVATIVE THEREOF AS GLP-1R AGONIST

2y 9m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

55%

Grant Probability

74%

With Interview (+19.2%)

2y 10m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1322 resolved cases by this examiner. Grant probability derived from career allowance rate.